On Wednesday, Eli Lilly raised its revenue forecast for this year to at least $28 billion and announced estimates for next year that beat Wall Street expectations, hoisting shares of the Indianapolis drugmaker by more than 9%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,